Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Phytera signs R&D and marketing agreement with NeuroSearch

May 19, 1998

Biovector licenses DNA delivery technology from NIH

May 19, 1998

CombiChem achieves milestone in Roche Bioscience collaboration

May 18, 1998

Phytera and Galileo enter into collaborative agreement

May 18, 1998

Andaris granted U.S. patent for microcapsule technology

May 15, 1998

CombiChem achieves milestone in collaboration with Teijin

May 14, 1998

VP22 provides intercellular delivery of functional p53 protein

May 14, 1998

Evotec awarded German grant for drug discovery

May 13, 1998

Rights to bgh gene tool available from RCT

May 12, 1998

Invitrogen will market reagents based on Phogen's VP22 technology

May 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...